from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3318/sdhA

LFCtreatmentdescriptionclass of inhibitor

-1.390

Amikacinug/mL Amikacintranslation

-2.194

Cap5-10ug/mL Capreomycintranslation

-2.350

Rox10-50 ug/mL Roxithromycintranslation

-0.355

SM2-5 ug/mL Streptomycintranslation

-0.744

Tet5-10 ug/mL Tetracyclinetranslation

0.502

Rif0.2-5ug/mL Rifampicintranscription

-0.438

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.836

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.792

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.649

CPZ10-50 ug/mL Chlorpromazinerespiration

0.365

Clofazimine10-13 ug/mL Clofaziminerespiration

0.662

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.104

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.261

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.040

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.744

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.743

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.758

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.197

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.663

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.407

KCN5-20 ug/mL Potassium cyaniderespiration

0.928

NaN30.2-2 mM Sodium aziderespiration

0.460

Nigericin50 uM Nigericinrespiration

-0.681

TRC10-150 ug/mL Triclosanrespiration

-0.253

TRZ10-25 ug/mL Thioridazinerespiration

-2.035

Valinomycin0.5-10 uM Valinomycinrespiration

1.021

ZnSO42 mM ZnSO4respiration

0.154

menadione6-10 ug/mL Menadionerespiration

0.331

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.401

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.322

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.675

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.712

NRP_1Non-replicating persistence stage 1dosRassociated

0.606

Amp0.2mg/mL AmpicillincellWall

0.346

Cephalexin20-100 ug/mL CephalexincellWall

0.371

Cerulenin0.32-5 ug/mL CerulenincellWall

0.704

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.537

EMB10-20 ug/mL EthambutolcellWall

1.084

Eta12-40 ug/mL EthionamidecellWall

0.362

INH0.2-0.4 ug/mL IsoniazidcellWall

0.711

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.172

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.267

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.491

BZA0.12 mg/mL BenzamidearomaticAmides

0.296

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.401

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.394

H2O24 mM hydrogen peroxideDNAdamaging

-0.273

Levo10 ug/mL LevofloxacinDNAdamaging

0.272

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.762

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.423

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.062

UVUV-irradiationDNAdamaging

-0.968

ARP41-4 ug/mL Antitubercular compound ARP4?

0.473

Antimycin12.5-50 ug/mL Antimycin A?

0.358

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.865

PA_110-50 ug/mL Antitubercular compound PA-1?

0.826

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.527

PA8240.2-2 ug/mL PA-824?

-0.325

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.237

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.428

Verapamil50 uM Verapamil?

0.630

mercaptoethanol2 mM 2-Mercaptoethanol?

0.487

methoxatin10-20 ug/mL Methoxatin?